Codexis, Inc. (NASDAQ: CDXS) provides unique, state-of-the-art enzyme optimization services and developing biocatalyst products. The company’s technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients (APIs), fine chemicals, agrochemicals, food ingredients, detergents and biofuels. They also enable rapid transfer to commercial manufacturing scale. Additionally, Codexis offers enzyme optimization and supply from small scale through to commercial quantities, and has developed and produced enzymes for more than 10 commercial processes. For more information, visit the company’s website at www.codexis.com.